๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small-cell lung cancer

โœ Scribed by M Oka; M Fukuda; M Kuba; M Ichiki; T Rikimaru; H Soda; J Tsurutani; Y Nakamura; S Kawabata; K Nakatomi; F Narasaki; S Nagashima; H Takatani; M Fukuda; A Kinoshita; S Kohno

Book ID
117659024
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
109 KB
Volume
38
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II trial of irinotecan and cisplat
Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer
โœ Joo Hyuk Sohn; Yong Wha Moon; Chang Geol Lee; Gwi Eon Kim; Kyung Young Chung; Jo ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 91 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND. A Phase II trial of irinotecan and cisplatin (IP) with early concurrent radiotherapy was performed in limitedโ€disease smallโ€cell lung cancer (LDโ€SCLC) to evaluate the efficacy and toxicity. ## METHODS. For untreated LDโ€SCLC patients, irinotecan (60 mg/m^2^, Days 1, 8,

Irinotecan and cisplatin with concurrent
Irinotecan and cisplatin with concurrent split-course radiotherapy in locally advanced nonsmall-cell lung cancer : A multiinstitutional phase 2 study
โœ Minoru Fukuda; Hiroshi Soda; Masaaki Fukuda; Akitoshi Kinoshita; Yoichi Nakamura ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 184 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND. The purpose was to determine the efficacy and toxicity of irinotecan and cisplatin with concurrent splitโ€course thoracic radiotherapy (TRT) in locally advanced nonsmallโ€cell lung cancer. ## METHODS. Fifty patients fulfilling the following eligibility criteria were enro